Dare Bioscience (DARE) Operating Leases (2020 - 2025)
Historic Operating Leases for Dare Bioscience (DARE) over the last 6 years, with Q3 2025 value amounting to $898000.0.
- Dare Bioscience's Operating Leases fell 3603.99% to $898000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $898000.0, marking a year-over-year decrease of 3603.99%. This contributed to the annual value of $754383.0 for FY2024, which is 1938.14% down from last year.
- As of Q3 2025, Dare Bioscience's Operating Leases stood at $898000.0, which was down 3603.99% from $1.0 million recorded in Q2 2025.
- Dare Bioscience's Operating Leases' 5-year high stood at $1.6 million during Q1 2024, with a 5-year trough of $90346.0 in Q4 2022.
- In the last 5 years, Dare Bioscience's Operating Leases had a median value of $826191.5 in 2024 and averaged $819637.3.
- Within the past 5 years, the most significant YoY rise in Dare Bioscience's Operating Leases was 93573.26% (2023), while the steepest drop was 7421.6% (2023).
- Quarter analysis of 5 years shows Dare Bioscience's Operating Leases stood at $384000.0 in 2021, then tumbled by 76.47% to $90346.0 in 2022, then surged by 935.73% to $935743.0 in 2023, then fell by 19.38% to $754383.0 in 2024, then grew by 19.04% to $898000.0 in 2025.
- Its Operating Leases was $898000.0 in Q3 2025, compared to $1.0 million in Q2 2025 and $1.2 million in Q1 2025.